Condition: Desmoplastic Small Round Cell Tumor · Sponsor: Italian Sarcoma Group
Patients participating in this study have DSRCT that has spread locally or to other parts of the body and can no longer be surgically removed without causing significant harm. Treatment will continue until the tumor progresses further, severe side effects occur, or either patient or investigator decision. In addition, patients may participate in an optional biological study. The study will analyze the tumor's genes and the molecules related to them. By studying genes and their products, the investigators can better understand the behavior of the tumor and how the body responds to therapies.
This description comes directly from the study's public registry record.
Gianluca Ignazzi · +393335359192 · gianluca.ignazzi@italiansarcomagroup.org
Viviana Appolloni · +393756073789 · viviana.appolloni@italiansarcomagroup.org
Always discuss trial participation with your own doctor first.
| Fondazione del Piemonte per l'Oncologia IRCCS | Candiolo, Torino, Italy | Recruiting |
| Fondazione IRCCS Istituto Nazionale dei Tumori | Milan, Italy | Recruiting |
| IOV Istituto Oncologico Veneto IRCCS | Padova, Italy | Recruiting |
| Nuovo Ospedale "S.Stefano" | Prato, Italy | Recruiting |
| Fondazione Policlinico Universitario Campus Bio-Medico | Roma, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07328425